Description
Interstitial lung diseases (IDLs) are a diverse group of pulmonary disorders characterized
by disruption of the lung tissue resulting in pulmonary fibrosis and progressive difficulty
breathing. The diagnosis of specific IDLs is not straightforward. There
is often doubt over the diagnosis such that recommendations have been made to utilize
multidisciplinary discussions between specialists who are experienced in the diagnosis
of ILD.
The purpose of this study is to provide lung tissue samples
for the optimization of a genomic test that will provide a range of diagnostic
and prognostic information about IDLs.
Location: Peninsula/South Bay
Contact: Veronica Luna LunaV1@sutterhealth.org
Principal Investigator
Funder
Veracyte, Inc.
Related Studies
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
Investigator: Ellis C. Dillon, Ph.D.
Can diet- and exercise-induced weight loss improve asthma control in obese adults?
Case Management and Environmental Support to Sustain Weight Loss and Reduce CHD Risk
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE)
Investigator: Ganesh Krishna, M.D.
Measurement of Quality of Life and Perceived Disease Impact on Quality of Life in Asthma
Investigator: Sandra Wilson, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigators: Jiang Li, Ph.D., MPH, Dorothy Hung, Ph.D., M.A., MPH
Prescription Amphetamine-based Stimulants and Pulmonary Hypertension
Investigators: Robert Romanelli, Ph.D., MPH, Sandra Wilson, Ph.D.
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH